SB203580 pretreatment showed a profound dosage-dependent induction of IL-10 in combination with LPS, but the levels of IL-10 expression in healthy PBMCs were highly significant than that in COPD patients.
← all excerpts
In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
1
—
—